Іздеу

Шығарылым
Атауы
Авторлар
Primenenie kombinirovannoy terapii glimepiridom i metforminom u patsientov s sakharnym diabetom 2 tipa. Rezul'taty Rossiyskogo observatsionnogo issledovaniya
Zaytseva N., Shamkhalova M.
Ispol'zovanie preparatov, proizvedennykh po novym tekhnologiyam, v lechenii nealkogol'nogo steatogepatita
Kazyulin A., Babina S.
VOZMOZhNOSTI DIBIKORA V KORREKTsII METABOLIChESKIKh I SOSUDISTYKh NARUShENIY U BOL'NYKh KhRONIChESKOY SERDEChNOY NEDOSTATOChNOST'Yu I SAKhARNYM DIABETOM 2 TIPA
Statsenko M., Vinnikova A., Shilina N., Ronskaya A.
Upravlenie lipotoksichnost'yu v debyute sakharnogo diabeta 2 tipa
Ametov A., Tertychnaya E.
Metabolicheskiy sindrom u bol'nykh sakharnym diabetom i ego korrektsiya preparatami tioktovoy kisloty
Kurnikova I.
SAKhARNYY DIABET 2 TIPA I NEALKOGOL'NAYa ZhIROVAYa BOLEZN' PEChENI: PRAKTIChESKIE REKOMENDATsII DLYa ENDOKRINOLOGOV
Ametov A.
Vybor gliptinov v raznykh klinicheskikh situatsiyakh - kommentarii k portretam patsientov
Ruyatkina L., Sorokin M.
Rol' taurina i ego defitsita v organizme cheloveka i zhivotnykh
Antsiferov M.
Rol' terapevticheskogo obucheniya patsientov na pompovoy insulinoterapii
Ametov A., Valitov B., Chernikova N., Antsiferov M.
PLACE OF DIBCOR® IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND METABOLIC SYNDROME
Vorokhobina N., Kuznetsova A., Vorohobina N., Kuznetsova A.
TYPE 2 DIABETES MELLITUS AND CONCOMITANT DISEASES: ADVANTAGES OF USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITOR SAXAGLIPTIN (ONGLYZA ®)
Antsiferov M., Petunina N., Antsiferov M., Petunina N.
Galvus and Galvus Met in treatment of elderly patients with type 2 diabetes mellitu
Antsiferov M., Antciferov M.
CLINICAL AND METABOLIC EFFICIENCY OF DRUG DIBIKOR IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Severina T., Popkova E., Trel'skaya N., Emel'yanov V., Severina T., Popkova Y., Trelskaya N., Yemelyanov V.
COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS
Petunina N., Trukhina L., Petunina N., Truhina L.
ROLE OF SPECIALIZED NUTRITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: CLINICAL EXPERIENCE OF USING OF GLUCERNA SR
Antsiferov M., Morgunov L., Antsiferov M., Morgunov L.
ADIPONECTIN AND C-REACTIVE PROTEIN AS FACTORS OF CARDIOVASCULAR RISK IN MEN WITH TYPE 2 DIABETES MELLITUS
Morkovskikh N., Morkovskikh N.
New possibilities for diabetic peripheral neuropathy treatment
Komelyagina E., Antsiferov M., Komelyagina E., Antsiferov M.
SOVREMENNYY VZGLYaD NA INSULINOTERAPIYu U BOL'NYKh SAKhARNYM DIABETOM
Ametov A., Karpova E.
MEKhANIZM DEYSTVIYa I KLINIChESKOE PRIMENENIE METFORMINA (SIOFOR®): OBZOR LITERATURY
Demidova I., Gorokhova T.
Insulin pump therapy - a way to achieve clinical and metabolic compensation of the disease in children and adolescents with type 1 diabetes mellitus
Petryaykina E., Dukhareva O., Rybkina I., Pronina E., Mikhaylova T., Garyaeva I., Mandzhieva E., Petryaikina E., Duchareva O., Ryibkina I., Pronina E., Michailova T., Garyaeva I., Mandjieva E.
Clinical effects of dapagliflozin in patients with type 2 diabetes mellitus and paroxysmal atrial fibrillation
Bagriy A., Prikolota O., Prikolota A., Mikhailichenko E., Golodnikov I., Bagriy O., Kotova K.
Efficacy and safety of ertugliflozin: results of the VERTIS CV sub-study in patients receiving a stable dose of insulin
Novikova M., Koteshkova O., Antsiferov M.
Differentiated approach to metformin therapy in newly diagnosed type 2 diabetes mellitus from the perspective of pharmacogenetics
Shorokhova P., Baranov V.
Experience of insulin degludec treatment using constant glucose monitoring system (CGMS)
Smirnova E.
Practical aspects of the use of semaglutide (Ozempic®) in real clinical practice
Antsiferov M., Zilov A., Koteshkova O., Demidov N.
Improvement of the efficacy of conservative treatment of rhinosinusitis and otitis media in patients with type 2 diabetes mellitus: an open-label prospective randomized clinical trial
Shkurova N., Baranova N., Fedin A.
Cranial neuropathy as a complication of diabetes mellitus
Maksimova M., Stepanchenko O.
Experience in the integrated use of organizational approaches and clinical tools to achieve glycemic control goals
Antsiferov M., Demidov N.
The place of glyflozins in the management of type 2 diabetes mellitus
Sharonova L., Verbovoy A.
Diabetic autonomic neuropathy: problems of diagnosis and therapy
Kurnikova I., Yurovsky A.
Features of glycemic control in patients with type 2 diabetes mellitus and chronic heart failure
Demidova T., Titova V.
Efficiency of different schemes of antihelicbacter therapy in patients with chronic gastroduodenal diseases and type 2 diabetes mellitus
Fedorchenko Y., Martynyuk M.
Fixed-dose combinations in the therapy of type 2 diabetes mellitus: the way to achieving good glycemic control
Biryukova E.
INSULIN RESISTANCE SYNDROME IN THE CLINIC OF INTERNAL DISEASES
Verbovoy A., Sharonova L., Pashentseva A., Tsanava I.
Effect of glucagon-like peptide-1 receptor agonist on cardiovascular risk markers in patients with type 2 diabetes mellitus
Mkrtumyan A., Podachina S., Sviridova M.
EFFICIENCY OF MULTICOMPONENT THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (CLINICAL CASE)
Koteshkova O., Molina L.
Kombinirovannaya tsitostaticheskaya i angioprotektivnaya terapiya bol'nykh psoriazom
Bakulev A., Utts S., Shtoda Y.
Sakharosnizhayushchaya terapiya i serdechno- sosudistaya bezopasnost'
Pashentseva A., Verbovoy A.
Alogliptin - effektivnyy i bezopasnyy ingibitor dipeptidilpeptidazy-4 v terapii bol'nykh sakharnym diabetom 2 tipa
Mkrtumyan A.
Effektivnost' i bezopasnost' primeneniya dvukhfaznogo analoga insulina NovoMiks 30 pri sakharnom diabete 2 tipa: ot klinicheskikh issledovaniy do real'noy praktiki
Surkova E.
Sakharnyy diabet i osteoporoz. Analiz kombinirovannogo podkhoda k lecheniyu
Doskina E.
METFORMIN - NADEZhNYY PARTNER V LEChENII PATsIENTOV S SAKhARNYM DIABETOM 2 TIPA
Petunina N., Kuzina I.
Preimushchestva novoy fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysbozhdeniya v terapii sakharnogo diabeta 2 tipa
Ametov A.
Effektivnyy i bezopasnyy kontrol' glikemii s pomoshch'yu Diabetona MV: zalog uspeshnoy profilaktiki khronicheskikh oslozhneniy sakharnogo diabeta 2 tipa
Biryukova E., Danilova T.
FARMAKOEKONOMIChESKIY ANALIZ PREIMUShchESTV KOMBINIROVANNOY INKRETINOVOY TERAPII BOL'NYKh SAKhARNYM DIABETOM 2 TIPA NA PRIMERE VILDAGLIPTINA
Arinina E., Rashid M., Antsiferov M.
Antiagregantnaya terapiya u patsientov s sakharnym diabetom, perenesshikh mozgovoy insul't
Matkevich E., Grapov D., Maksimov M.
Znachenie antioksidantnoy terapii v lechenii diabeticheskoy polinevropatii
Galstyan K.
Vliyanie ingibitorov dipeptidilpepti-dazy-4 na funktsional'noe sostoyanie miokarda u bol'nykh sakharnym diabetom 2 tipa
Ametov A., Kulidzhanyan N., Shurupova I., Trifonova T., Antsiferov M.
DIABETES IN CHILDREN AND ADOLESCENTS: TO THE 90TH ANNIVERSARY OF THE INTRODUCTION OF INSULIN IN CLINICAL PRACTICE
Peterkova V., Peterkova V.
DIPEPTIDYL PEPTIDASE-4 INHIBITORS - NEW POTENTIALS FOR TREATMENT OF TYPE 2 DIABETES MELLITUS: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW
Antsiferov M., Antciferov M.
DIABETIC AUTONOMIC NEUROPATHY AND DIGESTIVE ORGANS
Pogromov A., Baturova V., Pogromov A., Yu Baturova V.
INITIATION OF THERAPY WITH INSULIN PUMP IN PATIENTS WITH TYPE 1 DIABETES
Antsiferov M., Koteshkova O., Kleymenova S., Antsiferov M., Koteshkova O., Kleimenko S.
WHEN TO BEGIN COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS
Petunina N., Petunina N.
ANTIOXIDANT THERAPY OF DIABETIC POLYNEUROPATHY
Tabeeva G., Azimova Y., Tabeeva G., Azimova Y.
Advance - movement forward
Petunina N., Petunina N.
OPTIMIZATsIYa INSULINOTERAPII SAKhARNOGO DIABETA TIPA 1 V PERIOD BEREMENNOSTI
Demidova I., Mel'nikova E., Arbatskaya N., Ignatova N.
Insulin resistance and heart diseases: is there a relationship?
Drapkina O., Smirin V., Ivashkin V., Drapkina O., Smirin V., Ivaschkin V.
Possibilities of insulin glargine (Lantus ®) use for treatment of type 2 diabetes mellitus in the outpatient endocrinology services: an analysis of the register LAUREL
Antsiferov M., Petraneva E., Anciferov M., Petraneva E.
Efficacy and safety of fixed combination insulin glargine 100 u/ml and lixisenatide in patients with type 2 diabetes mellitus depending on age and baseline HbA1C in the SOLO study
Antsiferov M., Demidov N., Safronova T., Mishra O.
The role of menopausal hormone therapy in the prevention of type 2 diabetes melltus in postmenopausal women
Apetov S., Apetova V.
School of diabetes: new education module on insulin pump for patients with type 1 diabetes mellitus
Lisker A., Volkova A., Chernaya M., Mozgunova V., Durdyeva M.
Experience of using the new ultrafast-acting insulin Fiasp® in patients on insulin pump therapy: a case report
Barsukov I., Demina A.
Predictors of severe course of disease and high mortality among patients with COVID-19 and diabetes mellitus
Ivanova M., Zhurtova I., Sizhazheva S., Gubachikova A.
Resistin levels and metabolic parameters in patients type 2 diabetes mellitus in combination with hypothyroidism
Verbovoy T., Lomonova T.
Features of the treatment of patients with type 2 diabetes mellitus and morbid obesity
Amosova M., Gurova O., Fadeev V.
Statins and the risk of diabetes: an evidence-based review
Leonova M.
Potential drug interactions of oral hypoglycemic drugs that increase the risk of hypoglycemia
Pereverzev A., Ostroumova O., Tkacheva O.
Genetic predictors of the pharmacological effects of dipeptidyl peptidase-4 inhibitors and sulfonylureas in patients with type 2 diabetes mellitus
Shorokhova P., Baranov V., Vorokhobina N., Shpilevaya O.
Apelin: biological and pathophysiological effects
Dolgikh Y., Verbovoy A.
Opportunities for prevention of changes in skin and oral mucosa in diabetes mellitus at the present stage
Verbovoy A., Sharonova L., Burakshayev S., Kotelnikova E., Smirnova T.
Energy metabolism corrector Mildronate®: interrelation of mechanisms of action and therapeutic effects
Dzerve V.
ANGIOTENSIN II RECEPTOR BLOCKERS AND ENDOTHELIAL DYSFUNCTION: FOCUS ON NEPHROCEREBRAL INTERACTIONS
Murkamilov I., Aytbaev K., Yusupov F.
Modern approaches to the treatment of patients with type 2 diabetes mellitus
Antsiferov M., Fadeev V., Morgunova T.
PATHOGENETIC THERAPY OF DIABETIC POLYNEUROPATHY
Badalyan O., Savenkov A.
Vozmozhnosti primeneniya insulina detemir pri lechenii sakharnogo diabeta u beremennykh: dokazannye preimushchestva i perspektivy ispol'zovaniya
Ruyatkina L., Sorokin M.
Vliyanie Aktovegina na reparatsiyu khronicheskikh ran razlichnoy etiologii
Dibirov M., Gadzhimuradov R., Khalidov O., Kakubava M., Polyanskiy M.
Ingibitory SGLT-2: farmakologicheskaya glyukozuriya kak novyy podkhod v upravlenii SD 2 tipa
Demidova T.
Issledovanie ORIGIN (Outcome Reduction with Initial Glargine INtervention) 2 goda spustya: chto novogo?
Glinkina I.
FAKTORY RISKA RAZVITIYa OSTEOPOROZA
Akimova D.
TsENTRAL'NYY NESAKhARNYY DIABET: V ChEM SEKRET EFFEKTIVNOGO LEChENIYa?
Biryukova E.
Farmakoterapiya diabeticheskoy nevropatii: chto eshche krome kontrolya glikemii?
Biryukova E., Danilova T.
Preparaty tioktovoy kisloty v lechenii erektil'noy disfunktsii u bol'nykh sakharnym diabetom
Kurnikova I.
SODERZhANIE VITAMINA D 3 I POKAZATELI METABOLIZMA KOSTNOY TKANI U ZhENShchIN S SAKhARNYM DIABETOM 2 TIPA
Verbovoy A., Sharonova L., Verbovaya N., Demidova D., Kapishnikov A.
Diabeticheskaya retinopatiya i makulyarnyy otek. Algoritmy diagnostiki i lecheniya klinicheski znachimykh form
Shadrichev F.
Rannee naznachenie insulina glargin patsientam s sakharnym diabetom 2 tipa, prediabetom i vysokim serdechno-sosudistym riskom: rezul'taty issledovaniya ORIGIN
Antsiferov M., Biryukova E., Zilov A.
Farmakoterapiya, mestnye i dopolnitel'nye metody lecheniya pri sindrome diabeticheskoy stopy
Obolenskiy V., Nikitin V., Leval' P., Ermolova D., Molochnikov A., Ermolov A.
HOW TO OVERCOME THE EFFECTS OF "HYPERGLYCEMIC" MEMORY?
Biryukova E., V Biryukova Y.
GLUCAGON-LIKE PEPTIDE-1: FROM PHYSIOLOGY TO EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Antsiferov M., Antsiferov M.
DIABETIC GASTROENTEROPATHY: THE PATHOGENESIS AND DIFFERENTIAL TREATMENT APPROACH (LITERATURE REVIEW)
Demicheva T., Demicheva T.
INTENSIVE INSULIN THERAPY IN ACUTE CEREBROVASCULAR ACCIDENT
Demidova I., Makova A., Demidova I., Makova A.
DIABETIC NEPHROPATHY: DOES ANGIOTENSIN-CONVERTING ENZYME INHIBITORS MAINTAIN PRIORITY POSITION?
Fomin V., Pulin A., Saginova E., Fomun V., Pulin A., Saginova E.
INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS: A CHOICE AND AN INDIVIDUAL APPROACH
Biryukova Y., Biryukova E.
Thiazide diuretics and arterial hypertension: the history is going on
E Chazova I., Fomin V., Chazova I., Fomin V.
Sulfonylurea drugs and risk of cardiovascular complications - much ado about nothing?
Nedosugova L., Nedosugova L.
KLINIChESKIE NABLYuDENIYa PATsIENTOV S OSTEOPOROZOM I ENDOKRINNOY PATOLOGIEY
Belyaeva E.
Peculiarities of antihypertensive therapy in metabolic syndrome and diabetes mellitus
Mychka V., Zhernakova Y., Chazova I., Michka V., Jernakova Y., Chazova I.
Do all we know about the thiazolidinediones, or what pioglitazone differs from rosiglitazone?
Mkrtumyan A., Mkrtumyan A.
Vildagliptin - new opportunities in the treatment of type 2 diabetes mellitus
Pavlova M.
P-cell dysfunction in type 2 diabetes mellitus: the possibilities of modern antihyperglycemic therapy
Chernikova N.
New possibilities of using the FreeStyle Libre Flash-glucose monitoring system. FreeStyle Libre software ecosystem in Russia
Demidov N.
Нәтижелер 354 - 101/200 << < 1 2 3 4 > >> 
Сыбырсөздер:
  • Негізгі сөздер тіркелімге сезімтал< / li>
  • Ағылшын предлогтары мен одақтары еленбейді
  • Әдепкі бойынша іздеу барлық негізгі сөздер үшін жасалады (агенс AND экспериенцер)
  • Белгілі бір терминді табу үшін OR қолданыңыз. білім беру OR оқыту
  • мысалы, күрделі сөз тіркестерін жасау үшін жақшаларды қолданыңыз. мұрағат ((журналдар OR конференциялар) NOT диссертациялар)
  • Нақты фразаны табу үшін, мысалы, тырнақшаларды қолданыңыз. "ғылыми зерттеулер"
  • сөзді - (сызықша) немесе not операторының көмегімен алып тастаңыз; мысалы. сұлулық байқауы< / em > немесе сұлулық байқауы< / em > < / li>
  • мысалы, нұсқа ретінде * қолданыңыз. ғылым* "ғылыми","ғылыми"және т. б. сөздерді қамтиды< / li> < / < / к-сі>

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>